Compare MRVI & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | STKL |
|---|---|---|
| Founded | 2014 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.8M | 768.0M |
| IPO Year | 2020 | 1999 |
| Metric | MRVI | STKL |
|---|---|---|
| Price | $3.53 | $6.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $4.57 | ★ $7.83 |
| AVG Volume (30 Days) | 1.1M | ★ 3.8M |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.29 | ★ 186.67 |
| EPS | N/A | ★ 0.13 |
| Revenue | $185,743,000.00 | ★ $817,715,000.00 |
| Revenue This Year | $11.80 | $13.82 |
| Revenue Next Year | $7.74 | $6.95 |
| P/E Ratio | ★ N/A | $49.58 |
| Revenue Growth | N/A | ★ 12.99 |
| 52 Week Low | $1.67 | $3.32 |
| 52 Week High | $4.11 | $6.94 |
| Indicator | MRVI | STKL |
|---|---|---|
| Relative Strength Index (RSI) | 54.74 | 78.11 |
| Support Level | $3.25 | $5.73 |
| Resistance Level | $3.65 | $6.53 |
| Average True Range (ATR) | 0.18 | 0.05 |
| MACD | 0.07 | -0.07 |
| Stochastic Oscillator | 63.11 | 55.17 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.